WNT11 is a direct target of early growth response protein 1.


Journal

BMB reports
ISSN: 1976-670X
Titre abrégé: BMB Rep
Pays: Korea (South)
ID NLM: 101465334

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 09 03 2020
pubmed: 9 7 2020
medline: 24 8 2021
entrez: 9 7 2020
Statut: ppublish

Résumé

WNT11 is a member of the non-canonical Wnt family and plays a crucial role in tumor progression. However, the regulatory mechanisms underlying WNT11 expression are unclear. Tumor necrosis factor-alpha (TNFα) is a major inflammatory cytokine produced in the tumor microenvironment and contributes to processes associated with tumor progression, such as tumor invasion and metastasis. By using site-directed mutagenesis and introducing a serial deletion in the 5'-regulatory region of WNT11, we observed that TNFα activates the early growth response 1 (EGR1)-binding sequence (EBS) in the proximal region of WNT11 and that the transcription factor EGR1 is necessary for the TNFα-induced transcription of WNT11. EGR1 bound directly to the EBSs within the proximal 5'-regulatory region of WNT11 and ectopic expression of EGR1 stimulated WNT11 promoter activity, whereas the knockdown of EGR1 expression by RNA interference reduced TNFα-induced WNT11 expression in T47D breast cancer cells. We also observed that mitogen-activated protein kinases (MAPK), extracellular signalregulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38 kinase mediated TNFα-induced transcription of WNT11 via EGR1. Our results suggest that EGR1 directly targets WNT11 in response to TNFα stimulation in breast cancer cells. [BMB Reports 2020; 53(12): 628-633].

Identifiants

pubmed: 32635983
pii: 4973
pmc: PMC7781917

Substances chimiques

EGR1 protein, human 0
Early Growth Response Protein 1 0
Tumor Necrosis Factor-alpha 0
Wnt Proteins 0
Wnt11 protein, human 0
JNK Mitogen-Activated Protein Kinases EC 2.7.11.24
Mitogen-Activated Protein Kinases EC 2.7.11.24
p38 Mitogen-Activated Protein Kinases EC 2.7.11.24
MAP Kinase Kinase 4 EC 2.7.12.2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

628-633

Références

Cell. 2012 Dec 21;151(7):1542-56
pubmed: 23260141
Trends Cancer Res. 2016 Jan 1;11(1):1-27
pubmed: 27928197
Methods Mol Biol. 2006;338:281-90
pubmed: 16888365
Cancers (Basel). 2019 Jun 04;11(6):
pubmed: 31167446
Rheumatol Int. 1998;17(5):185-92
pubmed: 9542779
Cancer Res. 2010 Nov 15;70(22):9298-308
pubmed: 20870744
Oncogene. 2011 Apr 28;30(17):2044-56
pubmed: 21242973
Nat Rev Cancer. 2009 Apr;9(4):239-52
pubmed: 19279573
Prog Nucleic Acid Res Mol Biol. 1995;50:191-224
pubmed: 7754034
Science. 1987 Nov 6;238(4828):797-9
pubmed: 3672127
Oncogene. 2017 Mar;36(11):1461-1473
pubmed: 27617575
Int J Mol Med. 2009 Aug;24(2):247-51
pubmed: 19578797
Mol Biol Rep. 2019 Feb;46(1):317-324
pubmed: 30417207
J Biol Chem. 2009 Jan 23;284(4):2275-84
pubmed: 19049962
J Biol Chem. 2005 Jul 22;280(29):26825-37
pubmed: 15923644
Cell. 2005 Mar 25;120(6):857-71
pubmed: 15797385
Leukemia. 2019 May;33(5):1063-1075
pubmed: 30770859
J Biol Chem. 2004 Jun 18;279(25):26707-15
pubmed: 15084607
Biochem Biophys Res Commun. 2008 Oct 3;374(4):777-82
pubmed: 18675783
BMB Rep. 2019 Jul;52(7):451-456
pubmed: 31072445
J Biol Chem. 1992 Jan 15;267(2):1345-9
pubmed: 1730654
Mol Cell Biochem. 1996 Mar 9;156(1):69-77
pubmed: 8709978
Nature. 2002 Dec 19-26;420(6917):860-7
pubmed: 12490959
Br J Cancer. 2009 Oct 20;101(8):1374-81
pubmed: 19773752
Acta Physiol (Oxf). 2012 Jan;204(1):52-64
pubmed: 21447091
Tumour Biol. 2016 Sep;37(9):11789-11798
pubmed: 27034261
Cancer Res. 2007 May 15;67(10):5017-24
pubmed: 17510434
Nat Rev Cancer. 2009 May;9(5):361-71
pubmed: 19343034
Cell. 2017 Jun 1;169(6):985-999
pubmed: 28575679

Auteurs

JuHwan Kim (J)

Department of Biological Sciences, Sanghuh College of Lifesciences, Konkuk University, Seoul 05029, Korea.

Euitaek Jung (E)

Department of Biological Sciences, Sanghuh College of Lifesciences, Konkuk University, Seoul 05029, Korea.

Sung Shin Ahn (SS)

Department of Biological Sciences, Sanghuh College of Lifesciences, Konkuk University, Seoul 05029, Korea.

Hyunjin Yeo (H)

Department of Biological Sciences, Sanghuh College of Lifesciences, Konkuk University, Seoul 05029, Korea.

Jeong Yeon Lee (JY)

Department of Biological Sciences, Sanghuh College of Lifesciences, Konkuk University, Seoul 05029, Korea.

Jeong Kon Seo (JK)

Central Research Facilities, Ulsan National Institute of Science and Technology, Ulsan 44919, Korea.

Young Han Lee (YH)

Department of Biological Sciences, Sanghuh College of Lifesciences, Konkuk University, Seoul 05029, Korea; Cancer and Metabolism Institute, Konkuk University, Seoul 05029, Korea.

Soon Young Shin (SY)

Department of Biological Sciences, Sanghuh College of Lifesciences, Konkuk University, Seoul 05029, Korea; Cancer and Metabolism Institute, Konkuk University, Seoul 05029, Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH